{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:15:32Z","timestamp":1792120532393,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jaip.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:52:43Z","timestamp":1652842363000},"page":"1964-1973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-8189","authenticated-orcid":false,"given":"Jonathan J.","family":"Lyons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.05.003_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.05.003_bib2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.05.003_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.05.003_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2022.05.003_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","article-title":"Factors influencing serum total tryptase concentrations in a general adult population","volume":"48","author":"Gonzalez-Quintela","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jaip.2022.05.003_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2022.05.003_bib9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.anai.2021.06.019","article-title":"Inherited and acquired determinants of serum tryptase levels in humans","volume":"127","author":"Lyons","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0076-6879(94)44008-5","article-title":"Tryptase: a mast cell serine protease","volume":"244","author":"Schwartz","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jaip.2022.05.003_bib11","series-title":"Clinical approach to a patient with elevated serum tryptase: implications of acute versus basally elevated levels. 1st ed.","first-page":"35","author":"Lyons","year":"2020"},{"key":"10.1016\/j.jaip.2022.05.003_bib12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","article-title":"Tryptase genetics and anaphylaxis","volume":"117","author":"Caughey","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib13","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","article-title":"Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells","volume":"170","author":"Schwartz","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","article-title":"Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology","volume":"39","author":"Sperr","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaip.2022.05.003_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.anai.2021.08.009","article-title":"Clinical relevance of inherited genetic differences in human tryptases: hereditary alpha-tryptasemia and beyond","volume":"127","author":"Glover","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000501079","article-title":"Why the 20%\u00a0+ 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome","volume":"180","author":"Valent","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.05.003_bib18","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1016\/j.jaip.2021.06.011","article-title":"Selecting the right criteria and proper classification to diagnose mast cell activation syndromes: a critical review","volume":"9","author":"Gulen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.003_bib19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/all.13226","article-title":"Validation of international consensus equation for acute serum total tryptase in mast cell activation: a perioperative perspective","volume":"72","author":"Baretto","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.003_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/all.13752","article-title":"Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: an observational study","volume":"74","author":"Vitte","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.003_bib21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaip.2018.01.006","article-title":"Diagnostic value of tryptase in food allergic reactions: a prospective study of 160 adult peanut challenges","volume":"6","author":"Dua","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.003_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4168\/aair.2014.6.4.304","article-title":"The utility of serum tryptase in the diagnosis of food-induced anaphylaxis","volume":"6","author":"Wongkaewpothong","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2022.05.003_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000339749","article-title":"Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients","volume":"160","author":"Sala-Cunill","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jaci.2015.09.001","article-title":"Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors","volume":"137","author":"De Schryver","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaci.2021.08.007","article-title":"Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis","volume":"149","author":"Mateja","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ACI.0000000000000813","article-title":"Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker","volume":"22","author":"O'Connell","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib27","doi-asserted-by":"crossref","unstructured":"Waters AM, Park HJ, Weskamp AL, Mateja A, Kachur ME, Lyons JJ, et\u00a0al. Elevated basal serum tryptase: disease distribution and variability in a regional health system. J Allergy Clin Immunol Pract. Published online January 12, 2022. https:\/\/doi.org\/10.1016\/j.jaip.2021.12.031","DOI":"10.1016\/j.jaip.2021.12.031"},{"key":"10.1016\/j.jaip.2022.05.003_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2022.05.003_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib31","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK Prevalence and Variability in Disease Expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.003_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib33","doi-asserted-by":"crossref","unstructured":"Chovanec JF, Tunc I, Hughes J, Halstead J, Mateja A, Liu Y, et\u00a0al. Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms. medRxiv. Preprint published online May 2, 2022. https:\/\/doi.org\/10.1101\/2022.04.29.22274379","DOI":"10.1101\/2022.04.29.22274379"},{"key":"10.1016\/j.jaip.2022.05.003_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coi.2021.04.001","article-title":"Mast cell tryptases in allergic inflammation and immediate hypersensitivity","volume":"72","author":"Lyons","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.anai.2021.12.008","article-title":"Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans","volume":"128","author":"Glover","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2021.08.011","article-title":"On the complexities of tryptase genetics and impacts on clinical phenotypes","volume":"148","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib38","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/j.jaip.2021.03.005","article-title":"The genetic basis and clinical impact of hereditary alpha-tryptasemia","volume":"9","author":"Luskin","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.003_bib39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2019.05.007","article-title":"GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects","volume":"144","author":"Desai","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2017.08.039","article-title":"Persistent tryptase elevation in a patient with Gaucher disease","volume":"6","author":"Schussler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.003_bib41","doi-asserted-by":"crossref","first-page":"15900","DOI":"10.1038\/s41598-018-34233-w","article-title":"Surveillance of CKD epidemiology in the US\u2014a joint analysis of NHANES and KEEP","volume":"8","author":"Myers","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2022.05.003_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2018050531","article-title":"Projecting ESRD incidence and prevalence in the United States through 2030","volume":"30","author":"McCullough","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jaip.2022.05.003_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","article-title":"Epidemiology, prognosis, and risk factors in mastocytosis","volume":"34","author":"Brockow","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.05.003_bib44","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.3390\/cancers13246380","article-title":"A\u00a0multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years' experience of the GISM network","volume":"13","author":"Zanotti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaip.2022.05.003_bib45","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2020.11.017","article-title":"Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology","volume":"147","author":"Giannetti","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib46","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2022.05.003_bib47","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jaci.2021.04.004","article-title":"Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia","volume":"148","author":"Konnikova","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib48","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2022.05.003_bib49","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.1016\/S0021-9258(19)68496-6","article-title":"Tryptase from human pulmonary mast cells. Purification and characterization","volume":"256","author":"Schwartz","year":"1981","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2022.05.003_bib50","doi-asserted-by":"crossref","first-page":"19670","DOI":"10.1074\/jbc.274.28.19670","article-title":"Human tryptases alpha and beta\/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft","volume":"274","author":"Huang","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2022.05.003_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-2836(02)00625-3","article-title":"The crystal structure of human alpha1-tryptase reveals a blocked substrate-binding region","volume":"321","author":"Marquardt","year":"2002","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaip.2022.05.003_bib52","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.iac.2020.06.007","article-title":"Targeting mast cells with biologics","volume":"40","author":"Lyons","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.05.003_bib53","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.4049\/jimmunol.164.12.6566","article-title":"Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families","volume":"164","author":"Caughey","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2008.01.019","article-title":"Chimerism, point mutation, and truncation dramatically transformed mast cell delta-tryptases during primate evolution","volume":"121","author":"Trivedi","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib55","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.169.9.5145","article-title":"Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity","volume":"169","author":"Wang","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2022.05.003_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2022.05.003_bib57","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","article-title":"Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal","volume":"5","author":"Valent","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.jaip.2022.05.003_bib58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in Hymenoptera allergic patients regularly missed using baseline tryptase levels alone","volume":"148","author":"Selb","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822004895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822004895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:32:50Z","timestamp":1761975170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822004895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213219822004895"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.05.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}